Hedge fund Irenic urges Canadian firm Kinaxis to run a strategic review
Adds details on inbound interest, statement from company in paragraphs 5-6
By Svea Herbst-Bayliss
NEW YORK, Sept 17 (Reuters) -Hedge fund Irenic Capital Management on Tuesday urged Kinaxis KXS.TO to see who may want to buy the Canadian software company and warned its board against making "reactive decisions" and taking "half measures."
The board "should initiate a full strategic review including soliciting interest for a sale for the whole company," Irenic said in a statement, echoing other investors' private and public calls for the company to put itself up for sale.
Irenic, run by former Elliott Investment Management and Indaba Capital Management executives Adam Katz and Andy Dodge, called Kinaxis a "world-class software asset" that needs to find a new chief executive officer and head of sales and also needs to review interest in the company from potential financial and strategic buyers.
Earlier on Tuesday the supply chain management software supplier said it had hired Goldman Sachs, without disclosing the purpose. But it also said the board "strongly believes that execution of its strategic plan is the best path to maximize shareholder value."
Irenic said Kinaxis' new Executive Chairman Robert Courteau said there has been inbound interest from financial sponsors, but the board was currently unwilling to engage them.
"The Board is focused on enhancing value for shareholders, is fully aware of its fiduciary duties, and will continue to act accordingly," a Kinaxis spokesperson said.
The spokesperson did not directly respond to a request for comment on what interest the company has received and how it is engaging.
Irenic said the board cannot make decisions about the "best path forward without first considering alternative paths," expressing concern the board is not fully examining potential interest in the company.
Investment firm Daventry Group last week publicly urged Kinaxis to put itself up for sale, calling it a high quality asset that many buyers would pay a "healthy premium" to own.
Daventry, together with its affiliates, beneficially owns or controls approximately 1.4% of the outstanding stock of Kinaxis, which has a market value of about $3.2 billion.
Reporting by Svea Herbst-Bayliss; Editing by David Gregorio and Jamie Freed
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
